Afzal N Chaudhry Selected Research

Afzal N Chaudhry Research Topics

Disease

5	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 01/2017 - 07/2009
4	Vasculitis (Vasculitides) 12/2014 - 07/2009
4	Systemic Lupus Erythematosus (Libman-Sacks Disease) 12/2014 - 05/2010
4	Autoimmune Diseases (Autoimmune Disease) 12/2014 - 05/2010
3	Microscopic Polyangiitis 01/2017 - 07/2012
3	Neoplasms (Cancer) 03/2013 - 05/2010
2	Infections 05/2014 - 11/2010
2	Acromegaly 03/2013 - 07/2011
2	Pituitary Neoplasms (Pituitary Adenoma) 03/2013 - 07/2011
2	Glomerulonephritis 05/2010 - 09/2001
2	Hemorrhage 11/2002 - 09/2001
1	Behcet Syndrome (Behcet's Syndrome) 10/2015
1	Systemic Vasculitis 12/2014
1	Reinfection 05/2014
1	Renal Insufficiency (Renal Failure) 02/2014
1	Interstitial Lung Diseases (Interstitial Lung Disease) 02/2014
1	Apnea 03/2013
1	Acute Kidney Injury (Acute Renal Failure) 01/2013
1	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 07/2012
1	Necrosis 05/2012
1	Lupus Nephritis 11/2010
1	Proteinuria 11/2010
1	Inflammation (Inflammations) 05/2010
1	Death (Near-Death Experience) 01/2010
1	Brain Death (Brain Dead) 01/2010
1	Delayed Graft Function 01/2010
1	Neutropenia 07/2009
1	Chronic Hepatitis (Chronic Active Hepatitis) 01/2009
1	Congenital Generalized Lipodystrophy (Berardinelli-Seip Congenital Lipodystrophy) 01/2009
1	Lipodystrophy 01/2009
1	Membranoproliferative Glomerulonephritis (Membranoproliferative Glomerulonephritis, Type II) 01/2009
1	Anti-Glomerular Basement Membrane Disease (Goodpasture's Syndrome) 11/2003
1	Hyperkalemia 11/2002
1	Thrombocytopenia (Thrombopenia) 11/2002

Drug/Important Bio-Agent (IBA)

6	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2017 - 07/2009
3	Rituximab (Mabthera)FDA Link 05/2014 - 07/2009
2	Peroxidase (Myeloperoxidase)IBA 02/2014 - 07/2012
2	Insulin-Like Growth Factor I (IGF-1)IBA 03/2013 - 07/2011
2	AutoantigensIBA 07/2012 - 11/2003
2	Biomarkers (Surrogate Marker)IBA 06/2010 - 05/2010
1	Alemtuzumab (Campath)FDA Link 10/2015
1	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2014
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 12/2014
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 05/2014
1	Immunoglobulin G (IgG)IBA 05/2014
1	Intravenous Immunoglobulins (IVIG)FDA Link 05/2014
1	Immunoglobulins (Immunoglobulin)IBA 05/2014
1	GlucocorticoidsIBA 05/2014
1	Immunosuppressive Agents (Immunosuppressants)IBA 02/2014
1	CreatinineIBA 02/2014
1	LigandsIBA 03/2013
1	Somatostatin Receptors (Somatostatin Receptor)IBA 03/2013
1	lanreotide (Somatuline)FDA Link 03/2013
1	P 11 (P-11)IBA 03/2013
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 01/2013
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2013
1	Angiotensin Receptor AntagonistsIBA 01/2013
1	Myeloblastin (Proteinase 3)IBA 07/2012
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 07/2011
1	Prednisolone (Predate)FDA LinkGeneric 11/2010
1	Monoclonal AntibodiesIBA 11/2010
1	Antigen-Antibody Complex (Immune Complex)IBA 05/2010
1	AutoantibodiesIBA 05/2010
1	serum P-component (CIt)IBA 01/2010
1	dicarboxydine (DCD)IBA 01/2010
1	Complement System Proteins (Complement)IBA 01/2009
1	Complement C4 (Complement Component 4)IBA 01/2009
1	Triglycerides (Triacylglycerol)IBA 01/2009
1	Complement C3 Nephritic FactorIBA 01/2009
1	Heparin (Liquaemin)FDA LinkGeneric 11/2002
1	type IV collagen alpha3 chain (Goodpasture antigen)IBA 09/2001
1	Collagen Type IV (Type IV Collagen)IBA 09/2001
1	AntibodiesIBA 09/2001

Therapy/Procedure

6	Therapeutics 10/2015 - 07/2009
2	Remission Induction 10/2015 - 07/2009
1	Plasma Exchange 02/2014
1	Drug Therapy (Chemotherapy) 05/2010
1	Cardiopulmonary Bypass (Heart-Lung Bypass) 11/2002